Top compounds associated with response to CCDC151


Feature Type Standardized
Nominal ANOVA
mRNA canertinib CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0006
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0007
mRNA Bleomycin CTRPv2 pan-cancer AAC -0.13 0.0008
mRNA SNX-2112 CTRPv2 pan-cancer AAC -0.11 0.0008
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0009
mRNA phenformin GDSC1000 pan-cancer AAC 0.1 0.001
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.001
mRNA BMS-536924 CTRPv2 pan-cancer AAC -0.12 0.001
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
Download CSV